Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPURE.L Regulatory News (PURE)

  • There is currently no data for PURE

LTIP Options

10 Jul 2012 07:00

RNS Number : 2708H
PureCircle Limited
10 July 2012
 



PURECIRCLE LIMITED

("PureCircle" or "the Company")

Long Term Incentive Plan (LTIP) Options - New Options Granted and Exercised by Directors

 

PureCircle (LSE: PURE), the world's largest producer and marketer of high purity stevia provides an update of new options granted and options exercised and vested under the Company's LTIP.

The Board of PureCircle had on 10 July 2012 granted options to certain Directors of the Company. These options include:

(1) discretionary LTIP award granted to an Executive Director which shall vest on the third anniversary of the grant at Nil exercise price; and

(2) options granted to certain Non-Executive Directors in lieu of their fees covering 6-month period from 1 July 2012 to 31 December 2012. These options have an exercise price of GBP1.3715 per share (US$2.1343 per share), calculated based on 20 days weighted average closing price prior to 1 July 2012. These options shall vest on 1 January 2013.

Details of the options granted are provided in the table below.

Options previously granted to Non-Executive Directors have been vested and exercised on 10 July 2012 and were satisfied by the Company's Treasury shares at the exercise price of GBP1.15 per share (US$1.84 per share). Total options exercised were 36,600 and details are set out in the table below.

Director

Options Granted on 10 July 2012

Options Exercised on 10 July 2012

Options Outstanding

Mr M Malsagov (Executive)

Nil

Nil

456,000

W Mitchell (Executive)

35,000

Nil

316,000

Mr P Lai (Non-Executive)

11,700

13,550

11,700

Mr O Maes (Non-Executive)

Nil

12,200

Nil

Mr J Slosar (Non-Executive)

9,400

10,850

9,400

Total

56,100

36,600

793,100

Following the above options exercised, total issued ordinary shares is 154,566,294 of which 38,142 are held as treasury shares. The number of voting rights in the Company is 154,528,152. This figure should be used by shareholders as the denominator for the notification of their interest in the Company under the FSA's Disclosure and Transparency Rules.

Application has been made to AIM for the shares released from treasury to be admitted to trading on AIM.

 

For more information:

PureCircle Limited (www.purecircle.com)

Magomet Malsagov, CEO

+60 1 2388 8049

William Mitchell, CFO

 +44 7974 005 163

RFC Ambrian Ltd (NOMAD)

Stephen Allen

+61 8 9480 2500

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCRLMTTMBJMTJT
Date   Source Headline
14th Mar 20117:00 amRNSInterim Results and Investor Conference Call
13th Jan 20117:00 amRNSTrading Statement
15th Dec 201012:00 pmRNSAGM Statement
23rd Nov 20107:00 amRNSAGM Statement
9th Nov 20107:00 amRNSLong term incentive plan: Issue of shares
29th Oct 20107:00 amRNSDirector/PDMR Shareholding
28th Oct 20107:00 amRNSRe Audited accounts
23rd Sep 20108:08 amRNSRe Joint Venture
23rd Sep 20107:43 amRNSRe Joint Venture
22nd Sep 20107:00 amRNSRe Joint Venture
22nd Sep 20107:00 amRNSFull Year Results
31st Aug 20107:00 amRNSNotice of Allowance for patent
3rd Aug 20107:00 amRNSStevia Trust Mark marketing campaign
29th Jul 20107:00 amRNSRe Global Quality Leaf Sourcing Strategy
28th Jul 20107:00 amRNSMajor contract wins
27th Jul 20107:00 amRNSInterim Management Statement
27th Jul 20107:00 amRNSProposed Joint Venture
26th Jul 20107:00 amRNSGlobal Sales and Marketing VP appointed
21st Jul 20107:00 amRNSFDA 'No Objection' ruling on new product
25th Jun 201012:02 pmRNSGlobal Stevia Institute announces key members
26th May 20107:00 amRNSLaunch of Global Stevia Institute
5th May 20107:00 amRNSNew products launching at a greater rate
14th Apr 20106:25 pmRNSEFSA evaluates the safety of steviol glycosides
6th Apr 20107:00 amRNSUpdate on New Product Launches
1st Apr 20109:59 amRNSChange of significant Shareholding
30th Mar 201011:18 amRNSIssue of new shares and exercise of options
22nd Mar 20107:00 amRNSHalf Yearly Report
5th Mar 20107:00 amRNSNotice of Results
4th Mar 20107:00 amRNSProduct Launches
26th Feb 20107:00 amRNSManagement changes
22nd Feb 20107:00 amRNSRe Joint Venture
9th Feb 20109:27 amRNSChange of Significant Shareholding
1st Feb 20107:00 amRNSAppointment of Joint Corporate Broker
29th Jan 20107:00 amRNSProduct Launch
14th Jan 20109:09 amRNSRe Agreement
18th Dec 20097:00 amRNSSignificant shareholding
17th Dec 20097:00 amRNSSignificant Shareholders and Notifiable Interest
8th Dec 20099:11 amRNSissue of shares
24th Nov 200910:17 amRNSResult of AGM
23rd Nov 20097:00 amRNSNotifiable Interests
19th Nov 20097:00 amRNSissue of shares
18th Nov 20097:00 amRNSPlacing
16th Nov 20097:00 amRNSPureCircle collaboration with Nestle Malaysia
13th Nov 20097:00 amRNSPureCircle wins major award
11th Nov 20097:00 amRNSExpansion of supply source
6th Nov 20097:00 amRNSProduct Launch
4th Nov 20097:00 amRNSStevia product launches hit 200
2nd Nov 200911:15 amRNSAnnual Financial Report
30th Oct 20097:00 amRNSNotice of AGM
30th Oct 20097:00 amRNSStatement re Collaboration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.